TGF-beta repression of Id2 induces apoptosis in gut epithelial cells

Y Cao1, X Liu, W Zhang

  • 1Department of Surgery, University of Texas Health Science Center, Houston, TX 77030, USA. Yanna.Cao@uth.tmc.edu

Oncogene
|January 13, 2009
PubMed

Insights

Transforming growth factor-beta (TGF-beta) induces apoptosis in intestinal cells by repressing inhibitor of differentiation (Id) genes. Hypoxia-inducing factor-1 (HIF-1) is identified as a key mediator in this TGF-beta-induced apoptosis pathway.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor-beta (TGF-beta) is crucial for epithelial tissue homeostasis, regulating cell cycle arrest, differentiation, and apoptosis.
  • Dysregulation of the TGF-beta signaling pathway is frequently observed in colorectal cancers.
  • Previous studies established Smad3 as a transcription factor mediating TGF-beta-induced apoptosis.

Purpose of the Study:

  • To identify novel TGF-beta/Smad3 target genes involved in apoptosis regulation in rat intestinal epithelial cells (RIE-1).
  • To elucidate the molecular mechanisms downstream of TGF-beta signaling that control apoptosis.

Main Methods:

  • Affymetrix oligonucleotide microarrays were employed to profile gene expression changes induced by TGF-beta.
  • Gene knockdown and overexpression techniques were used to assess the functional roles of identified genes (Id1, Id2, HIF-1).
  • TranSignal Protein/DNA arrays were utilized to identify downstream targets of TGF-beta signaling.

Main Results:

  • TGF-beta was found to repress the expression of the inhibitor of differentiation (Id) gene family.
  • Knockdown of Id1 and Id2 expression promoted apoptosis in RIE-1 cells, while Id2 overexpression inhibited TGF-beta-induced apoptosis.
  • Hypoxia-inducing factor-1 (HIF-1) was identified as a downstream target of TGF-beta, and its activation was blocked by Id2 overexpression.
  • Knockdown of HIF-1 abrogated TGF-beta-induced apoptosis, establishing HIF-1 as a critical mediator.

Conclusions:

  • The inhibitor of differentiation 2 (Id2) acts upstream of hypoxia-inducing factor-1 (HIF-1) in the TGF-beta apoptotic pathway.
  • HIF-1 is identified as a novel mediator downstream of Id2 in TGF-beta-induced apoptosis.
  • These findings provide new insights into the molecular mechanisms underlying TGF-beta-mediated apoptosis in intestinal epithelial cells and its relevance to cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...